Inhibition of Pseudomonas aeruginosa by Peptide-conjugated Phosphorodiamidate Morpholino Oligomers.
Howard JJ, Sturge CR, Moustafa DA, Daly SM, Marshall-Batty KR, Felder CF, Zamora D, Yabe-Gill M, Labandeira-Rey M, Bailey SM, Wong M, Goldberg JB, Geller BL, Greenberg DE 2017 Jan Antimicrob. Agents Chemother.Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.
Ayhan DH, Tamer YT, Akbar M, Bailey SM, Wong M, Daly SM, Greenberg DE, Toprak E 2016 Sep PLoS Biol. 9 14 e1002552Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae.
Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE 2016 Jul Lancet Infect DisA novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.
Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM 2006 Apr PLoS Pathog. 4 2 e28Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
Pybus CA, Felder-Scott C, Obuekwe V, Greenberg DE, 2021 Jan Antimicrob Agents Chemother 2 65Combating resistance while maintaining innovation: the future of antimicrobial stewardship.
Vickers RJ, Bassetti M, Clancy CJ, Garey KW, Greenberg DE, Nguyen MH, Roblin D, Tillotson GS, Wilcox MH, 2019 Sep Future MicrobiolAntisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection.
Daly SM, Sturge CR, Marshall-Batty KR, Felder-Scott CF, Jain R, Geller BL, Greenberg DE 2018 Mar ACS Infect DisAntimicrobial Activity of Ibuprofen Against Cystic Fibrosis Associated Gram-Negative Pathogens.
Shah PN, Marshall-Batty KR, Smolen JA, Tagaev JA, Chen Q, Rodesney CA, Le HH, Gordon VD, Greenberg DE, Cannon CL 2018 Jan Antimicrob. Agents Chemother.Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.
Townsend J, Park AN, Gander R, Orr K, Arocha D, Zhang S, Greenberg DE 2015 Jan Open Forum Infect Dis 1 2 ofv023A 60-year-old man with necrotic skin lesions after heart transplantation.
Prokesch BC, Cavuoti D, Le JB, Greenberg DE 2014 Nov Am. J. Transplant. 11 14 2664-6Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo.
Geller BL, Marshall-Batty K, Schnell FJ, McKnight MM, Iversen PL, Greenberg DE 2013 Nov J. Infect. Dis. 10 208 1553-60Serologic reactivity to the emerging pathogen Granulibacter bethesdensis.
Greenberg DE, Shoffner AR, Marshall-Batty KR, Arora K, Zhao M, Martin R, Ding L, Hammer CH, Shaw PA, Kuhns DB, Malech HL, Gallin JI, Zarember KA, Holland SM 2012 Sep J. Infect. Dis. 6 206 943-51Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE 2012 Mar Infect. Immun. 3 80 975-81Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.
Greenberg DE, Shoffner AR, Zelazny AM, Fenster ME, Zarember KA, Stock F, Ding L, Marshall-Batty KR, Wasserman RL, Welch DF, Kanakabandi K, Sturdevant DE, Virtaneva K, Porcella SF, Murray PR, Malech HL, Holland SM 2010 Sep Emerging Infect. Dis. 9 16 1341-8Host-microbe interaction systems biology: lifecycle transcriptomics and comparative genomics.
Sturdevant DE, Virtaneva K, Martens C, Bozinov D, Ogundare O, Castro N, Kanakabandi K, Beare PA, Omsland A, Ohmsland A, Carlson JH, Kennedy AD, Heinzen RA, Celli J, Greenberg DE, DeLeo FR, Porcella SF 2010 Feb Future Microbiol 2 5 205-19